Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms
- 1 September 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 76 (7) , 453-458
- https://doi.org/10.1016/s0002-9149(99)80129-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Fibrinogen as a Cardiovascular Risk FactorAnnals of Internal Medicine, 1993
- Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study.Circulation, 1990
- GENETIC AND CULTURAL INHERITANCE OF PLASMA FIBRINOGEN CONCENTRATIONThe Lancet, 1987
- Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systemsBritish Journal of Haematology, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Left Ventricular Mural ThrombusArchives of internal medicine (1960), 1983
- Platelet function tests in thrombotic cerebrovascular disorders.Stroke, 1983
- A study of hemostasis in ischemic cerebrovascular disease I. Abnormalities in factor VIII and antithrombinThrombosis Research, 1982
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978